ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Apellis Pharmaceuticals (APLS)

Technical Analysis Report for USA stock APLS Apellis Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock APLS Apellis Pharmaceuticals then click here. or read Experts views on Apellis Pharmaceuticals or Forecast & share price targets of Apellis Pharmaceuticals

Apellis Pharmaceuticals Opened at 22.68 and Closed at: 23.49, which is 3.96% of previous session's close. It moved within a range of 22.57 and 23.58
The session was a Bullish session with an average volume of 1824900, which is -61.26% of previous session's volumes.

  • Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 2 days back on short term averages

Support for tomorrow is 23.03 and resistance for tomorrow is 24.04
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 22.85, 22.2 resistance for tomorrow's hourly charts is 23.86, 24.22

10 Day SMA for Apellis Pharmaceuticals (APLS) is 22.78 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Apellis Pharmaceuticals (APLS) is 22.28 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Apellis Pharmaceuticals (APLS) is 23.37 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 23.28 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Apellis Pharmaceuticals is 22.12 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Apellis Pharmaceuticals is at 22.28 and 200 DMA is at 22.12, while 50 DMA and 100 DMA are at 23.37 and 23.28 respectively

Apellis Pharmaceuticals (APLS) moving average of 20 SMA is at 22.28 and 20 EMA is at 22.83

Apellis Pharmaceuticals (APLS) moving average of 50 SMA is at 23.37 and 50 EMA is at 23.08

Apellis Pharmaceuticals (APLS) moving average of 100 SMA is at 23.28 and 100 EMA is at 23.19

Apellis Pharmaceuticals (APLS) moving average of 200 SMA is at 22.12 and 200 EMA is at 23.95

Apellis Pharmaceuticals has performed better than Concord Medical in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Apellis Pharmaceuticals has performed better than Boston Scientific in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Utah Medical has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Utah Medical, about 16.89% more returns!

Twist Bioscience has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Twist Bioscience, about 53.4% more returns!

Trupanion Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Trupanion Inc, about 6.23% more returns!

China Sxt has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in China Sxt, about 1947.32% more returns!

Apellis Pharmaceuticals has performed better than Summit Therapeutics in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Neurotrope Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Neurotrope Inc, about 3.73% more returns!

Neogenomics Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Neogenomics Inc, about 0.77% more returns!

Madrigal Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Madrigal Pharmaceuticals, about 6.9% more returns!

Halozyme Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 26.08% more returns!

Dexcom Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Dexcom Inc, about 17.8% more returns!

Denali Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Denali Therapeutics, about 37.48% more returns!

Apellis Pharmaceuticals has performed better than Collplant Holdings in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Beyondspring Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Beyondspring Inc, about 8.33% more returns!

Axsome Therapeutics has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 21.77% more returns!

Argenx Se has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Argenx Se, about 16.9% more returns!

Align Technology has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Align Technology, about 22.56% more returns!

Acadia Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 1.97% more returns!

Apellis Pharmaceuticals Technical analysis of indicators

Price action analysis of Apellis Pharmaceuticals (APLS) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Apellis Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Apellis Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Apellis Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 22.76 and Apellis Pharmaceuticals APLS stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Apellis Pharmaceuticals APLS stock. Volume based technical analysis of Apellis Pharmaceuticals APLS stock is negative.

Apellis Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock APLS Apellis Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And APLS Experts View which covers a lot of information including buying and selling signals

APLS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Apellis Pharmaceuticals or View Candle Stick Charts here

Chart Apellis Pharmaceuticals (APLS)  Technical (Analysis) Reports Apellis Pharmaceuticals [

Videos related to: Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Apellis Pharmaceuticals (APLS)  Technical (Analysis) Reports Apellis Pharmaceuticals [

 

Back to top